{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/bronchiectasis/diagnosis/diagnosis/","result":{"pageContext":{"chapter":{"id":"ce267b5b-70dd-52bd-ad83-6123bd42fa0d","slug":"diagnosis","fullItemName":"Diagnosis","depth":2,"htmlHeader":"<!-- begin field 757fd1e5-226d-4375-b3f2-930cfe53bd82 --><h2>When should I suspect bronchiectasis?</h2><!-- end field 757fd1e5-226d-4375-b3f2-930cfe53bd82 -->","summary":"","htmlStringContent":"<!-- begin item eca1714d-3595-4c1b-94db-6a1342723df2 --><!-- begin field ccfabffb-ec1c-4306-8112-f9075923124d --><ul><li><strong>Suspect bronchiectasis </strong><strong>in adults </strong><strong>with: </strong><ul><li>Persistent production of mucopurulent or purulent sputum, particularly with relevant associated risk factors for bronchiectasis.</li><li>A cough that persists for longer than 8 weeks, especially with sputum production or a history of an appropriate trigger (over 90% of people). </li><li>Rheumatoid arthritis if they have symptoms of chronic productive cough or recurrent chest infections.</li><li>Chronic obstructive pulmonary disease (COPD) with frequent exacerbations (two or more annually) and/or a positive sputum culture for <em><em>Pseudomonas</em> aeruginosa</em> (or another potentially pathogenic organism) whilst stable. </li><li>Asthma that is severe or poorly controlled.</li><li>Inflammatory bowel disease and chronic productive cough.</li></ul></li><li><strong>Clinical features of bronchiectasis include:</strong><ul><li>Daily expectoration of large volumes of purulent sputum (75% of people). </li><li>Dyspnoea (60% of people). </li><li>Fever. </li><li>Fatigue, reduced exercise tolerance. </li><li>Haemoptysis that can be frank (up to 10 mL) or massive (more than 235 mL) (26–51.2%). </li><li>Rhinosinusitis. </li><li>Weight loss. </li><li>Chest pain that is present between exacerbations and is usually non-pleuritic (19–46.3% of people). </li><li>Sputum colonization with <em>P. aeruginosa</em>. </li><li>Young age at presentation. </li><li>History of symptoms over many years. </li><li>Absence of smoking history. </li></ul></li><li><strong>On examination there might be:</strong> <ul><li>Coarse crackles, especially in the lower lung zones.</li><li>Wheeze. </li><li>High-pitched inspiratory squeaks. </li><li>Large airway rhonchi (low pitched snore-like sounds). </li><li>Palpable chest secretions on coughing or forced expiratory manoeuvre, persisting over time. </li><li>Finger clubbing (uncommon).</li></ul></li><li><strong>Suspect bronchiectasis in children with:</strong><ul><li>A chronic moist or productive cough unresponsive to 4 weeks of antibiotics, especially between viral colds, or with positive sputum cultures for <em>Staphylococcus aureus</em>, <em>Haemophilus influenza,</em> <em>P. aeruginosa, </em>non-tuberculosis mycobacteria, or <em>Burkholderia cepacia</em> complex. </li><li>A recurrent or persistent wet cough (over 6 weeks' duration). </li><li>Asthma that does not respond to treatment. </li><li>An episode of severe pneumonia, especially if symptoms, physical signs, or radiological changes do not completely resolve. </li><li>Recurrent pneumonia. </li><li>Persistent and unexplained physical signs or chest radiographic abnormalities. </li><li>Localized chronic bronchial obstruction. </li><li>Respiratory symptoms and structural or functional disorders of the oesophagus and upper respiratory tract. </li><li>Unexplained haemoptysis. </li><li>Exertional breathlessness. </li></ul></li><li><strong>On examination in children, there might be: </strong><ul><li>Finger clubbing. </li><li>Cyanosis.</li><li>Chest deformity and hyperinflation. </li><li>Persistent inspiratory crackles and wheeze (these are much less common). </li></ul></li><li><strong>Consider <a class=\"topic-reference internal-reference\" href=\"/topics/bronchiectasis/diagnosis/differential-diagnosis/\">alternative diagnoses</a> </strong>and be aware that bronchiectasis may co-exist with other conditions including COPD and asthma.</li><li><strong>Arrange <a class=\"topic-reference internal-reference\" href=\"/topics/bronchiectasis/management/suspected-bronchiectasis/#management\">investigations</a></strong> to help rule out other conditions.</li></ul><!-- end field ccfabffb-ec1c-4306-8112-f9075923124d --><!-- end item eca1714d-3595-4c1b-94db-6a1342723df2 -->","topic":{"id":"96a8622b-46f5-55fa-b729-6748e3d98c98","topicId":"26fab339-e333-44ec-a481-de87a29052f3","topicName":"Bronchiectasis","slug":"bronchiectasis","lastRevised":"Last revised in January 2021","chapters":[{"id":"43d88c30-f768-5e1c-a6ea-5596c5577fb5","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"ac4fde9a-5fd3-5ed9-9201-f714bda470bb","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"0b34af83-d49a-5145-8589-e8748b8646c0","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"04eeb1ae-4fc3-5418-83a2-b62587d8bdda","slug":"changes","fullItemName":"Changes"},{"id":"dbd8ad5a-871c-59b8-9729-444e11ac9df1","slug":"update","fullItemName":"Update"}]},{"id":"b89644c6-805f-50b4-991d-36bb2b0fbf67","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"d38de329-73b8-5fed-83ef-f836b765cd3f","slug":"goals","fullItemName":"Goals"},{"id":"3c116665-5586-5551-909c-0efc1ef0be62","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"60e13bc0-e351-5c39-b8ff-9a8d4514bf16","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"2ee37cc0-9ff4-5bbd-ab3f-0a30cb904bb5","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"d155aa4f-7dfe-575d-a7dd-a87774f4cbad","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"07c3e24b-c950-516e-9070-5441a07b3791","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"5146c866-f0a7-54a6-a5ac-8aff4b385cc6","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"e2107a7e-b7c3-5ba9-94e4-6217ea79a3f2","slug":"definition","fullItemName":"Definition"},{"id":"39df7c47-de08-57ae-aa40-89a7d4d7b031","slug":"causes","fullItemName":"Causes"},{"id":"ac4d346e-97d4-5d84-a704-fbdcf56be7f4","slug":"prevalence","fullItemName":"Prevalence"},{"id":"e07a8b0b-866c-5789-85ef-020a5b19b620","slug":"prognosis-complications","fullItemName":"Prognosis and complications"}]},{"id":"ef5c5e7b-3cf4-5939-85e0-b61cae41f945","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"ce267b5b-70dd-52bd-ad83-6123bd42fa0d","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"c605c0b9-0519-50e1-abd8-2dc47de7278a","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"},{"id":"23a1627d-30f7-5ba4-95f8-060faf797f51","slug":"suspected-infective-exacerbation-diagnosis","fullItemName":"Suspected infective exacerbation diagnosis"}]},{"id":"5a5846fa-c8b4-5cd4-b2d3-770c3dc00ba2","fullItemName":"Management","slug":"management","subChapters":[{"id":"0180d43c-dd8d-5a87-915c-629542f782fe","slug":"suspected-bronchiectasis","fullItemName":"Scenario: Suspected bronchiectasis"},{"id":"290c51ae-6521-5c03-b12e-117e40c88883","slug":"infective-exacerbation","fullItemName":"Scenario: Infective exacerbation"},{"id":"1e90ec28-8eea-5ab7-ac76-2df1ace279de","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"ba1a593e-f80b-5c5f-be50-5979b491bc70","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"6db0266e-4d15-5eec-b2c0-ed20f472eeb5","slug":"azithromycin","fullItemName":"Azithromycin"},{"id":"a98b5813-5589-5247-9c65-e9ae534d88c2","slug":"amoxicillin","fullItemName":"Amoxicillin"},{"id":"04c99c8f-7a1d-55f0-85a2-6d0e1bc3e4e3","slug":"ciprofloxacin","fullItemName":"Ciprofloxacin"},{"id":"26b521e3-9c5e-5a7c-956b-7f3f39f2e58c","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"6cd6079a-be84-5279-9d10-e3bf4653c049","slug":"co-amoxiclav","fullItemName":"Co-amoxiclav"},{"id":"8ed4a900-3e69-51c0-8cd5-c2b0bee9bfe2","slug":"doxycycline","fullItemName":"Doxycycline"},{"id":"5217d027-064d-5543-93b0-7e8bb1a1c0fc","slug":"erythromycin","fullItemName":"Erythromycin"},{"id":"cf1fbf18-e60a-54f7-bbc4-2a30ab37f565","slug":"flucloxacillin","fullItemName":"Flucloxacillin"},{"id":"8e888abe-cb05-5343-b6e3-547dea7312cc","slug":"beta-2-agonists","fullItemName":"Beta-2 agonists"}]},{"id":"118b4e08-e6ae-510a-b2f5-51b109ef3395","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"ecf8de37-d8f0-5ced-af38-9be20fa73de9","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"1c227675-02ea-5c9e-a927-e385987adf53","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"f74bbe64-1998-528f-b811-df2a14219de7","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"2a925d45-6865-5cd5-9624-23da53ee221a","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"a6ff3076-9be6-55b4-b373-f40cb3045f2c","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"67608f46-5eba-58f9-86e3-0e0e3f57d921","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"3fae7f8d-20fb-5fe6-af57-64882afceb3a","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"ef5c5e7b-3cf4-5939-85e0-b61cae41f945","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"11aaa849-d968-5a88-bcae-7ef90d149bc1","slug":"basis-for-recommendation-b36","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 5a55cfa7-1bbf-4da2-9737-bde1e1b367be --><h3>Basis for recommendation</h3><!-- end field 5a55cfa7-1bbf-4da2-9737-bde1e1b367be -->","summary":null,"htmlStringContent":"<!-- begin item b3651c06-c732-4e49-851d-712312fd2e34 --><!-- begin field 037e7963-a64d-4122-9b86-19ad39942723 --><p>These recommendations are based on the British Thoracic Society (BTS) <em>Guideline for non-CF bronchiectasis </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/bronchiectasis/references/\">BTS, 2010</a>], the BTS <em>Guideline for bronchiectasis in adults</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/bronchiectasis/references/\">BTS, 2019</a>], the British Medical Journal (BMJ) best practice guide <em>Bronchiectasis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/bronchiectasis/references/\">BMJ, 2020</a>], and expert opinion in narrative reviews <em>Paediatric and adult bronchiectasis: diagnosis, disease burden and prognosis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/bronchiectasis/references/\">Quint, 2019</a>], <em>Recurrent lower respiratory tract infections in children</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/bronchiectasis/references/\">de Benedictis, 2018</a>], and <em>Bronchiectasis in children: diagnosis and treatment</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/bronchiectasis/references/\">Chang, 2018</a>].</p><!-- end field 037e7963-a64d-4122-9b86-19ad39942723 --><!-- end item b3651c06-c732-4e49-851d-712312fd2e34 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}